Table 4.

EBOV mock clinical trial diagnostic performance

N	Positive predictive value	Negative predictive value	Sensitivity	Specificity	Prevalence
148	97.37% (83.95–99.62%)	90.00% (84.26–93.80%)	77.08% (62.69–87.97%)	99.00% (94.55–99.97%)	32.43% (24.98–40.61%)

Study design and demonstration of the preliminary diagnostic performance of an EBOV MIPS diagnostic assay. This table shows the diagnostic performance of the EBOV MIPS mock clinical trial. Numbers in parentheses represent the 95% confidence interval